Invesco Biotechnology & Genome ETF (ARCA: PBE) stock price, news, charts, stock research, profile.
Open | $70.52 |
High | $71.19 |
52 Wk High | 70.70 |
AUM | 271.00M |
Dividend | $0.06 |
Ex-Div Date | Jun 24, 2024 |
Volume | 19.93K |
Market Cap | $26.28B |
Mgmt Fee | 0.5% |
P/E Ratio | 28.60 |
Prev. Close | $70.10 |
Low | $70.52 |
52 Wk Low | 52.47 |
Shares Out | 4.04M |
Yield | 0.09% |
Div. Freq | Quarterly |
Avg. Volume Daily | 11.66K |
Beta | 0.81 |
Avg. Expense Ratio | NA% |
P/B Ratio | 3.79 |
You can purchase shares of Invesco Biotechnology & Genome ETF (ARCA:PBE) through any online brokerage.
There are no as such competitors for Invesco Biotechnology & Genome ETF.
There is no analysis for Invesco Biotechnology & Genome ETF.
There is no analysis for Invesco Biotechnology & Genome ETF to provide a consensus price target.
The stock price for Invesco Biotechnology & Genome ETF (ARCA: PBE) is $70.8443 last updated Today at July 26, 2024 at 8:00 PM EDT.
A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on September 28, 2018 to stockholders of record on September 24, 2018.
Invesco Biotechnology & Genome ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Invesco Biotechnology & Genome ETF.
Sector | Healthcare |
Category | High Performer-Mid Growth |
Investment Style | Mid Cap Growth |
Fund Inception | Jun 23, 2005 |
Managers | Tony Seisser Pratik Doshi Peter Hubbard Michael Jeanette |
Definition | This Equity Fund Portfolio contains majority of stocks with strong financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
BMRN | Biomarin Pharmaceutica... | 5.39% |
REGN | Regeneron Pharmaceutic... | 5.27% |
GILD | Gilead Sciences Inc | 5.23% |
INCY | Incyte | 5.16% |
VRTX | Vertex Pharmaceuticals... | 5.11% |
AMGN | Amgen Inc. | 5.07% |
ILMN | Illumina Inc | 4.97% |
NBIX | Neurocrine Biosciences... | 4.78% |
IONS | Ionis Pharmaceuticals ... | 3.37% |
HALO | Halozyme Therapeutics ... | 3.23% |